Literature DB >> 25669601

The use of rivaroxaban in patients with antiphospholipid syndrome: A series of 12 cases.

Maksim Son1, Ewa Wypasek2, Magdalena Celinska-Lowenhoff3, Anetta Undas4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25669601     DOI： 10.1016/j.thromres.2015.01.028

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  13 in total

Review 1.  Anticoagulating patients with high-risk acquired thrombophilias.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Direct oral anticoagulants in hypercoagulable states.

Authors:  Paul R Kunk; Jacqueline Brown; Melissa McShane; Surabhi Palkimas; B Gail Macik
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

Review 3.  The use of direct oral anticoagulants in inherited thrombophilia.

Authors:  Jessica W Skelley; C Whitney White; Angela R Thomason
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

Review 4.  Recurrent Thrombosis in Patients with Antiphospholipid Syndrome Receiving Newer Oral Anticoagulants: A Case Report and Review of Literature.

Authors:  Akanksha Joshi; Jason Hong; Chokkalingam Siva
Journal:  Clin Med Res       Date:  2017-06

Review 5.  Diagnosis and management of the antiphospholipid syndrome.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Blood Rev       Date:  2017-07-30       Impact factor: 8.250

Review 6.  Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.

Authors:  Virginie Dufrost; Jessie Risse; Stéphane Zuily; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

7.  Role of Novel Oral Anticoagulants in the Treatment of Antiphospholipid Syndrome.

Authors:  C Whitney White; Angela R Thomason; Katie Boyd
Journal:  Hosp Pharm       Date:  2016-10

8.  Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases.

Authors:  Flavio Signorelli; Felipe Nogueira; Vinicius Domingues; Henrique Ataide Mariz; Roger A Levy
Journal:  Clin Rheumatol       Date:  2015-07-30       Impact factor: 2.980

Review 9.  Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?

Authors:  Kimberly Janet Legault; Amaia Ugarte; Mark Andrew Crowther; Guillermo Ruiz-Irastorza
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

Review 10.  The antiphospholipid syndrome: still an enigma.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.